Epstein Secrets

ctor Matt Gorham will offer opening remarks on the new strategy, followed by an in-depth panel conversation moderated by McCrary Institute Director Frank Cilluffo and an audience question-and-answer session. The panel will consist of Gorham; Tonya Ugoretz, FBI deputy assistant director; and Clyde Wallace, FBI

g on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Lat

ctor Matt Gorham will offer opening remarks on the new strategy, followed by an in-depth panel conversation moderated by McCrary Institute Director Frank Cilluffo and an audience question-and-answer session. The panel will consist of Gorham; Tonya Ugoretz, FBI deputy assistant director; and Clyde Wallace, FBI

g on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Lat

ector Matt Gorham will offer opening remarks on the new strategy, followed by an in-depth panel conversation moderated by McCrary Institute Director Frank Cilluffo and an audience question-and-answer session. The panel will consist of Gorham; Tonya Ugoretz, FBI deputy assistant director; and Clyde Wallace, FBI

ring on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in La

ector Matt Gorham will offer opening remarks on the new strategy, followed by an in-depth panel conversation moderated by McCrary Institute Director Frank Cilluffo and an audience question-and-answer session. The panel will consist of Gorham; Tonya Ugoretz, FBI deputy assistant director; and Clyde Wallace, FBI

ng on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in La